NCT03116152 2021-02-03Study of IBI308 With Advanced/Metastatic Esophageal Squamous Cell Carcinoma After Failure of First-line TreatmentInnovent Biologics (Suzhou) Co. Ltd.Phase 2 Completed190 enrolled 14 charts